Elemy Poland Spółka z Ograniczoną Odpowiedzialnością (KRS 0000973590, NIP 5252909770) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. Elemy Poland operates in: Other human health activities n.e.c. (PKD 86.90.E). Industry: Healthcare. The company has been listed in the National Court Register since May 27, 2022. Elemy Poland's most recently reported net revenue was 0 PLN for 2022.
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Elemy Poland
Identity
- Name
- Elemy Poland Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- May 27, 2022
- Registry status as of
- July 3, 2026
- Latest entry
- July 3, 2026
- Founding act
- 01.02.2022, REPERTORIUM A NUMER 1050/2023, NOTARIUSZ RADOSŁAW WALASIK, KANCELARIA NOTARIALNA W WARSZAWIE, ZMIENIONO PAR.…
Articles of association history (2)
- February 17, 2022: 17.02.2022, NOTARIUSZ MARZENA DMOCHOWSKA, KANCELARIA NOTARIALNA W WARSZAWIE, REP. A NR 985/2022
- February 1, 2022: 01.02.2022, REPERTORIUM A NUMER 1050/2023, NOTARIUSZ RADOSŁAW WALASIK, KANCELARIA NOTARIALNA W WARSZAWIE, ZMIENIONO PAR. 2 PKT 1, PAR. 6 PKT 1, PAR. 11 I PRZYJĘTO NOWY TEKST JEDNOLITY UMOWY SPÓŁKI
Activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Elemy Poland
Credibility rating
47 / 100
Average credibility
Insolvency risk
Very low
Elevated threat
Closure risk
38
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/4 yrs
Board changes
1
1/4 yrs
PKD changes
1
1/4 yrs
Name changes
1
1/4 yrs
Data from 4 years of registry activity.
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Elemy Poland
Founded
May 27, 2022
4 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
86.90.E
Other human health activities n.e.c.
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
1 year
2022 · profitable: 0/1
Registry entries
9
latest: July 3, 2026
Risk signals
Revenue
0 PLN
2022
Net profit
-1.0 K PLN
2022
Assets
4.0 K PLN
2022
Equity
4.0 K PLN
2022
EBITDA
-1.0 K PLN
2022
Valuation
3.0 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Elemy Poland.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the world's first and Poland's first accredited longevity-medicine educational programme for doctors. Accreditation comes from the Polish Medical Chamber; the scientific partner is the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of a medical-imaging centre network (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. Founded in 2005 and listed on the WSE since 2011, it operates under the Voxel-Diagnostic brand at several dozen locations across Poland. According to its 2025 financial statements, revenue reached PLN 583.8 million (up 15% year on year) with net profit of PLN 98.5 million. A two-member management board, a five-member supervisory board.
